...
机译:PBPK 建模以预测艾伏尼布作为癌症患者的肇事者的药物相互作用以及 Simcyp 平台用于 CYP3A4 诱导的资格
Agios Pharmaceut Inc;
Simcyp Ltd;
EMD Serono Inc;
REGULATORY DECISION-MAKING; IN-VITRO DATA; CYTOKINE LEVELS; WORKING GROUP; PHARMACOKINETICS; TRANSPORTERS; SUBMISSIONS; 4-BETA-HYDROXYCHOLESTEROL; SIMULATION; LEUKEMIA;
机译:Characterization of Correction Factors to Enable Assessment of Clinical Risk from In Vitro CYP3A4 Induction Data and Basic Drug-Drug Interaction Models
机译:Characterization of Correction Factors to Enable Assessment of Clinical Risk from In Vitro CYP3A4 Induction Data and Basic Drug-Drug Interaction Models
机译:Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling (vol 61, pg 375, 2022)